Association between higher triglyceride glucose index and increased risk of osteoarthritis: data from NHANES 2015–2020

Osteoarthritis (OA) is a prevalent cause of impairment and a substantial factor in the financial burden experienced by older individuals [1‐3]. The prevalence of this illness has experienced a significant increase in recent decades, primarily due to the demographic shift towards an aging population and the escalating rate of obesity [4]. The economic impact of OA in several affluent countries has been estimated to account for approximately 1–2.5% of their gross domestic product [5]. Compared with 2020, there is an anticipated substantial increase in the prevalence of OA projected for the year 2050. The projected increase in prevalence rates for different types of OA are as follows: knee OA (KOA) is estimated to increase by 74.9% (with a range of 59.4–89.9), hand OA by 48.6% (with a range of 35.9–67.1), hip OA by 78.6% (with a range of 57.7-105.3), and other forms of OA by 95.1% (with a range of 68.1–135.0) [6]. Hence, it is vital to expeditiously recognize and intervene in instances of OA in order to mitigate its prevalence.

Insulin resistance (IR) is a prevalent feature observed in persons diagnosed with type 2 diabetes mellitus (T2DM), hypertension, dyslipidemia, and cardiovascular disease. It denotes a reduced responsiveness to the physiological impacts of insulin. Numerous observational studies have provided strong evidence indicating a noteworthy correlation between diabetes and OA, with the latter ascribed to insulin resistance [7]. The TyG index is derived through a mathematical computation involving the fasting triglyceride and glucose values’ logarithm. The indicator of IR, which is a precursor to T2DM, has been universally acknowledged as a distinct and reliable measure [8]. The evidence suggests a correlation between the TyG index and the prognosis of several illnesses, such as cardiovascular disease, kidney stones, erectile dysfunction, and dementia [9‐13].

Accumulating evidence suggests that IR may increase the risk of developing OA. In a study conducted by Martine Duclos et al. [14], it was observed that elevated blood glucose levels could lead to inflammation and cartilage degeneration through oxidative stress, accumulation of inflammatory mediators, and advanced glycation end-products. Florent Eymard et al. [15] suggested that T2DM prediction decreased joint space in men with established KOA. Additionally, it was noted by Daisuke Hamada et al. [16] T2DM could increase vulnerability to the beginning and development of OA by encouraging IR expression. Moreover, Zaharia et al. [17] demonstrated that IR is connected to both musculoskeletal function and symptoms of arthritis in both T2MD patients and metabolically healthy people. In addition, Bradley et al. [18] showed that leptin and the interleukin-1 receptor antagonist were connected to IR and OA strengthened the case for a link between T2DM and OA. Thus, there may be a connection between the TyG index and OA because it has been suggested that the TyG index is an IR marker. However, the correlation between TyG index and OA has never been examined in a prior study.

It is conceivable to speculate about a potential correlation between the TyG index and the occurrence of OA, given the claim that the TyG index serves as an indicator of IR. However, more investigation is required into the relationship between the TyG index and the prevalence of OA. Therefore, this study aims to examine the relationship between the TyG index and OA in a sizable, nationally representative cohort of Americans. The National Health and Nutrition Examination Survey (NHANES) from 2015 to 2020 provided the data for this investigation.

Our results show a statistically significant independent connection between raised TyG index levels and a higher likelihood of OA in this cross-sectional investigation, which included 25,514 participants. The subgroups stratified by age, gender, BMI, smoking status, and diabetes showed similarity in the detected link. Starting IR treatment and management earlier in life may have positive effects on reducing or preventing the occurrence of OA.

This is the first investigation of the relationship between the TyG index and OA. Numerous additional clinicopathological variables have been linked to OA in other research. Chen et al. [20] found a correlation between the frequency of OA and the levels of thyroid hormone sensitivity (central and peripheral). Lower blood 25-(OH)D levels were substantially and non-linearly linked to more significant risks of all-cause and cardiovascular diseases mortality in American people with OA, according to Xiao et al. [21]. Biological age, phenotypic age, and telomere length were revealed to have substantial mediating effects on the association of metals with OA risk by Chen et al. [22]. It has been shown in earlier research that inflammation and the TyG index are highly related. Li et al. [23] demonstrated that higher levels of inflammation and the TyG index, both individually and in combination, increased the risk of colorectal cancer. Moreover, Yan et al. [24] elucidated that among Americans under 60 with average weight and no diabetes, the TyG index was positively linked with arthritis. A combined predictor to represent innate and adaptive immunity in response to cancer, the systemic inflammatory response index (SIRI) was developed initially [25]. SIRI is a newly discovered biomarker for OA disease activity assessment [26]. The NF-κB and NLRP3 signaling pathways collaborate to support P2 × 7-induced chondrocyte extracellular matrix breakdown and pyroptotic inflammation, according to Li et al. [27]. In addition, Philpott et al. [28] showed how cannabidiol might delay the onset of chronic joint pain by inhibiting early OA-related inflammation. OA is a disease of the whole joint, affecting the synovium, tendons, muscles, ligaments, subchondral bone, adipose tissue, and articular cartilage. It may even be a systemic illness, with inflammation playing a crucial part in the interaction of the joint tissues [29]. Greene et al. [4] suggested that “inflame-aging”—or age-associated inflammation—and the onset of OA may be connected. Furthermore, the study conducted by Jin et al. [30] showed that limonin can inhibit NF-κB activation in chondrocytes. This inhibition occurs via the activation of the Nrf2/HO-1 cascade, significantly reducing the inflammatory response and catabolic processes induced by IL-1β. It has also been claimed that inflammation is favorably related to IR, and in TNF-treated Gulo-/- mice, Qing et al. [31] revealed that vitamin C deficiency worsens IR, which may partly be due to the loss of the anti-inflammation effect. Protein tyrosine phosphatase 1B (PTP1B) is a regulatory enzyme that catalyzes the removal of phosphate groups from phosphoserine residues found in insulin receptor and receptor substrate proteins. Additionally, it has been shown that the expression of PTP1B is increased in response to the pro-inflammatory cytokine TNF-α [32]. NF-κB activation via TLR4/MD-2 causes the production of NLRP3 and IL-1β and IL-18 precursors. When NLRP3 recognizes different DAMPs, it oligomerizes, activating caspase-1 and causing mature IL-1β and IL-18 to be produced. By serine phosphorylating IRS1/2, secreted IL-1 suppresses insulin receptor signaling and activates MAPKs via the IL-1 receptor (IL-1R) [33, 34]. In addition, obesity causes IR and macrophage infiltration in adipose tissue, the liver, and skeletal muscle [35]. TyG index has been considered a credible indication of IR, and as inflammation has been linked to both IR and OA, which may be positively correlated.

It needs to be clarified what causes the TyG index to be correlated with OA. Rosa et al. [36] have reported that chondrocytes express functional insulin receptors in human adults. In individuals with OA, chondrocytes have a diminished ability to enhance glucose transport in response to normal physiological levels of insulin. This impairment in glucose transport may harm energy production and the plastic functions of chondrocytes, including the synthesis of glucosaminoglycans. Ultimately, this can lead to chondrocyte damage and the progression of OA. Furthermore, studies have demonstrated that visceral fat, which serves as a substantial source of pro-inflammatory cytokines, can contribute to low-grade chronic metabolic inflammation. This inflammation can potentially lead to joint structural damage and is often associated with IR and T2DM [37]. Moreover, IR is crucial in controlling metabolic syndrome, which raises the risk of OA by maintaining joint inflammation [38]. The impairment of insulin’s ability to suppress the production of inflammatory and catabolic mediators responsible for OA would be diminished with the onset of IR in individuals with obesity. Insulin has a pivotal role as a significant modulator of synovial inflammation and catabolism. According to a publication, obese OA patients with T2DM have synovium that develops IR [16]. A greater TyG index is linked to a greater risk of OA, which may be explained by the TyG index’s positive correlation with the IR level.

Previous epidemiological research showed that OA risk factors included obesity, smoking, hypertension, and diabetes. Jiang et al. [39] discovered that females were substantially more likely than males to have KOA, with a 5-unit rise in BMI being linked to a 35% greater risk of the condition (p˂0.05). The pathophysiology of OA has previously been linked to vascular dysfunction [40]. Ching et al. [41] revealed that hypertension’s biophysical and biochemical effects on the synovium, subchondral bone, and chondrocytes disrupt joint homeostasis. They may be a factor in the development of OA. Smokers are more likely to develop spinal OA and have more intense and long-lasting pain than non-smokers, according to research by Felson et al. [42]. Thomas Rehling et al. [43] found that OA prevalence was strongly correlated with diabetes [1.3 (1.2–1.4), p˂0.001]. Our findings of the subgroup analysis show that, in line with previous research, the positive correlation was constant in subgroups stratified by gender, age, BMI, smoking, and diabetes. Furthermore, we found no dependency on BMI, smoking status, or diabetes for this connection (all p for interaction > 0.05), indicating that this positive correlation may be suitable for many demographic contexts. However, there existed a higher positive association between TyG index and OA in the individuals without diabetes (p for interaction < 0.05).

Current research has several advantages. The NHANES data were used in our investigation, and the appropriate NHANES sample weights were considered while performing the analyses. In addition, we used covariate modifications to lessen the impact of confounding variables, improving the dependability of our results and allowing them to be applied to a larger population. However, it is critical to recognize the constraints built into our research. Personal interviews were used to diagnose OA first, opening the door to the potential of recall bias. Lack of information on pertinent laboratory tests, such as anti-Cyclic Citrullinated Peptide antibodies and Rheumatoid Factor, for the diagnosis and differential diagnosis of OA is another limitation. Moreover, because of NAHNES database restrictions, individuals with OA did not have their occupation or comorbidities included as variables. Furthermore, it should be emphasized that the study design of the NHANES data did not specifically contain information about the differentiation between T1MD and T2MD diabetes. As a result, a more thorough investigation of this connection among subgroups stratified by T1MD and T2MD was not feasible. Furthermore, we chose to use only one imputation for managing the missing data, possibly affecting the accuracy of our findings, given that the missing values of the variables were randomly ignored and the sample size was large enough to draw a firm conclusion. The cross-sectional research design might be blamed for failing to prove a causal connection between TyG and OA.

This research indicates that elevated TyG index values are associated with a higher likelihood of OA prevalence. Hence, we postulate that TyG may serve as a valuable predictor for OA, contributing to the early identification and prevention of OA. However, further extensive prospective studies are necessary to clarify the precise cause of this relationship.